KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Work In Process (2016 - 2018)

Biogen has reported Work In Process over the past 9 years, most recently at $606.7 million for Q4 2018.

  • For Q4 2018, Work In Process changed 0.17% year-over-year to $606.7 million; the TTM value through Dec 2018 reached $606.7 million, changed 0.17%, while the annual FY2018 figure was $606.7 million, 0.17% changed from the prior year.
  • Work In Process for Q4 2018 was $606.7 million at Biogen, roughly flat from $605.7 million in the prior quarter.
  • Over five years, Work In Process peaked at $698.7 million in Q4 2016 and troughed at $511.5 million in Q4 2014.
  • A 5-year average of $600.0 million and a median of $605.7 million in 2017 define the central range for Work In Process.
  • Biggest five-year swings in Work In Process: grew 20.97% in 2016 and later decreased 13.31% in 2017.
  • Year by year, Work In Process stood at $511.5 million in 2014, then grew by 12.92% to $577.6 million in 2015, then grew by 20.97% to $698.7 million in 2016, then decreased by 13.31% to $605.7 million in 2017, then rose by 0.17% to $606.7 million in 2018.
  • Business Quant data shows Work In Process for BIIB at $606.7 million in Q4 2018, $605.7 million in Q4 2017, and $698.7 million in Q4 2016.